![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
20
Qinhuangdao Zizhu Pharmaceutical Co., Ltd. Qinhuangdao City Cn, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their significant offerings is Levonorgestrel, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2006-218 - Rev 01
This Chemical Type CEP, issued on February 27, 2014, remains in force until July 10, 2015, ensuring its reliability within the pharmaceutical industry.
Substance Number 926 associated with this CEP further emphasizes